KalVista start the clinical development of a new treatment for diabetic macular edema
KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces…
25/08/2014 - 3 minutes
KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces…